The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 36.60
Ask: 37.30
Change: 2.80 (8.24%)
Spread: 0.70 (1.913%)
Open: 35.00
High: 37.30
Low: 35.00
Prev. Close: 34.00
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: HSBC announces redemption of US dollar securities

Thu, 15th Apr 2021 19:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

HSBC Holdings PLC - London-based bank - Announces the redemption of its USD2.00 billion 6.875% perpetual subordinated contingent convertible securities. The redemption price will be USD1,000 per USD1,000 of the securities together with any accrued but unpaid interest.

----------

RHI Magnesita NV - Vienna, Austria-headquartered supplier of refractory products - Notes appointment of Non-Executive Director Janet Ashdown as an independent non-executive director of Stolt-Nielsen Ltd, listed on the Oslo Bors.

----------

Blue Star Capital PLC - investment company with a focus on esports, payments, technology and its applications within media and gaming - Says investee Dynasty eSports Pte Ltd achieved its first monthly profit on an operating basis in January. Says Dynasty expects to shortly conclude a round of fundraising in which it is targeting to raise approximately USD5 million. Blue Star retains anti-dilution rights and is considering exercising these rights to participate in Dynasty's fundraising round. Blue Star currently holds approximately 13% of Dynasty.

----------

Alliance Pharma PLC - pharmaceutical company based in Wiltshire - Says Non-Executive Director Nigel Clifford to step down on April 30 after serving for six years.

----------

Futura Medical PLC - Surrey-based pharmaceutical company - Receives conversion notice from HT Riverwood Multi-Growth Fund, managed by Atlantis Investment Management Ltd, for GBP1.5 million loan notes. Says following this there will be no further amounts outstanding to Riverwood. Says following the conversion, Futura will issue 7.5 million shares at a conversion price of 20 pence per share.

----------

CEPS PLC - Bath, England-based investment company focussed on the industrial sector - Says subsidiary Hickton Group Ltd enters a four-year GBP500,000 Coronavirus Business Interruption Loan with Santander UK PLC. Proceeds will be used for general corporate purposes. Says the loan is repayable in 11 consecutive equal quarterly payments starting approximately 12 months after drawdown.

----------

Tavistock Investments PLC - Berkshire-based investment manager - Says holders of 42% of its shares are against possible Team PLC offer. On Wednesday, Tavistock received letters of intent from holders of 25% of shares saying they will reject the possible all-share offer by Team. In addition, Tavistock board members, who own a 16% stake, would not accept an offer at that level from Team as it significantly undervalues the business. On March 23, Jersey-based investment manager Team announced a possible all-share offer for Tavistock worth GBP15.2 million, or 2.5 pence per share. Tavistock's market capitalisation is GBP15.8 million.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Withdraws application for maintenance of Europe Efmody orphan designation. Says this follows feedback from the Committee for Orphan Medicinal Products, an advisory committee to the European Medicines Agency. "Diurnal has decided that continuing pursuit of an Orphan Designation for the drug would be likely to cause a significant delay in its European commercial launch. First commercial launch is currently anticipated to be in Q3 2021," says Diurnal.

----------

Emmerson PLC - Khemisset potash project in northern Morocco - Completes phased development plan for Khemisset potash project. Expects "significantly reduced up-front capex" of USD254.6 million. Expects earnings before interest, tax, depreciation and amortisation in first full year of phase four production of USD491.4 million.

----------

CATCo Reinsurance Opportunities Fund Ltd - investor focused on offering returns from investments linked to catastrophe reinsurance risks - Advised of further side pocket investment release amounting to USD19.2 million. Says it is expected to be paid to the company in May, following which the company intends to use it to carry out a seventh compulsory redemption of its shares.

----------

Caerus Mineral Resources PLC - exploration & resource development company focused on minerals in Europe to supply global clean energy drive - Says drilling in Cyprus has begun ahead of schedule. Says Mines Department of Cyprus has accepted its applications for the Kapedes and Vrechia extension licences. Says formal granting of licences expected to take several months but will commence reconnaissance geological mapping and sampling in the interim.

----------

Valeura Energy Inc - Canada-based company engaged in the exploration, development and production of petroleum and natural gas in Turkey - Agrees with TBNG Ltd to amend long stop date for completion of the sale of its shallow conventional gas business for USD15.5 million. Valeura will be entitled to royalty payments over a five-year period, with a minimum royalty payment of USD1.0 million, and maximum of USD2.5 million.

----------

Chesterfield Resources PLC - copper explorer focused on Cyprus - Announces that it has commenced its 2021 mineral exploration campaign in Cyprus. The company is exploring for further copper, gold, zinc and silver, after its successful diamond drill programme of late 2020. Says 15 percussion drill holes are planned during April and May.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Aug 2023 12:07

IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia

Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed.

Read more
18 Jul 2023 14:16

Futura Medical chair steps down, promotes non-executive director

(Alliance News) - Futura Medical PLC on Tuesday said it appointed Non-Executive Chair Jeff Needham as the successor to outgoing chair John Clarke, who has stepped down.

Read more
17 Jul 2023 09:13

Futura Medical agrees US licensing deal with Haleon for Med3000 gel

(Alliance News) - Futura Medical PLC on Monday said it agreed a licensing deal with Haleon PLC for the rights to exclusively commercialise Futura's erectile dysfunction treatment Med3000 in the US.

Read more
17 Jul 2023 08:33

Futura Medical shares rise on ED licensing deal with Haleon

(Sharecast News) - Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical, gel-based erectile dysfunction treatment MED3000 in the USA.

Read more
22 Jun 2023 14:45

IN BRIEF: Futura Medical hails continued momentum after Eroxon launch

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says it is encouraged by the early growth trajectory of erectile dysfunction treatment gel Eroxon following its recent launch. "Both initial orders of Eroxon by our partners and in-market demand have been in line with our expectations and should continue to build as partners expand sales channels, numbers of outlets and new geographies," it adds. Predicts that net revenue for the six months ending June 30 will be no less than GBP1.5 million. Says momentum continues to build as it enters the commercialisation phase and positions itself to receive its first significant revenue in 2023. It previously in April said that its 2022 pretax loss widened to GBP6.9 million from GBP5.8 million the year before.

Read more
15 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Friday 16 June 
Alpha Growth PLCAGM
Anglo-Eastern Plantations PLCAGM
Gulf Keystone Petroleum LtdAGM
John Lewis of Hungerford PLCGM re proposed cancellation of admission to trading on AIM
Tesco PLCAGM
Woodbois LtdAGM
Monday 19 June 
All ThingsConsidered Group PLCAGM
Blackbird PLCAGM
Finsbury Food Group PLCAGM
Globalworth Real Estate Investments LtdAGM
Marlowe PLCGM re proposed capital reduction
Metals Exploration PLCAGM
Red Rock Resources PLCGM re security conversion into shares for cash
Savannah Resources PLCAGM
Tuesday 20 June 
Acceler8 Ventures PLCAGM
Afentra PLCAGM
Armadale Capital PLCAGM
Bay Capital PLCAGM
Blackrock Smaller Companies Trust PLCAGM
Block Energy PLCAGM
Corero Network Security PLCAGM
Coro Energy PLCAGM
Crimson Tide PLCAGM
Curtis Banks Group PLCAGM
EPE Special Opportunities LtdAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Jersey Oil & Gas PLCAGM
Kore Potash PLCAGM
Lords Group Trading PLCAGM
Mission Group PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Red Capital PLCAGM
Saga PLCAGM
SDX Energy PLCAGM
Skillcast Group PLCAGM
Zegona Communications PLCAGM
Wednesday 21 June 
Argentex Group PLCAGM
Clean Power Hydrogen PLCAGM
Eqtec PLCAGM
Hydrogen Utopia International PLCAGM
HSS Hire Group PLCAGM
Intelligent Ultrasound Group PLCAGM
JD.com IncAGM
RTW Venture Fund LtdAGM
Schroders Capital Global Innovation Trust PLCAGM
Sivota PLCAGM
Numis Corp PLCGM re acquisition by Deuche Bank AG
THG PLCAGM
UK Commercial Property REIT LtdAGM
Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM

 

Read more
12 Jun 2023 12:08

LONDON MARKET MIDDAY: Stocks firm as expected Fed pause still in doubt

(Alliance News) - Stock prices in London were tentatively higher at midday on Monday, as investors looked ahead to a key US inflation print on Tuesday with some caution ahead of the Federal Reserve's next interest rate decision.

Read more
12 Jun 2023 10:13

AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
12 Jun 2023 09:47

Futura shares jump after FDA approval for erectile dysfunction product

(Alliance News) - Futura Medical PLC said on Monday that the US Food & Drug Administration granted over the counter sale marketing authorising for MED3000, the company's treatment of erectile dysfunction.

Read more
18 Apr 2023 13:09

Futura's erection gel launched over-the-counter in the UK

(Sharecast News) - Sexual health-focussed pharmaceutical company Futura Medical announced on Tuesday that its topical gel formulation for the treatment of erectile dysfunction (ED), MED3000, is now available in the UK under the 'Eroxon' brand.

Read more
18 Apr 2023 12:32

Futura launches Eroxon erectile dysfunction gel in UK stores

(Alliance News) - Futura Medical PLC announced on Tuesday that its erectile dysfunction treatment gel Eroxon is now available for purchase in the UK.

Read more
5 Apr 2023 12:21

Futura Medical annual loss widens as eyes MED3000 progress

(Alliance News) - Futura Medical PLC said on Wednesday its annual loss widened as it focused on the commercialisation of its new MED3000 product.

Read more
29 Mar 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 30 March 
AO World PLCTrading Statement
Aquis Exchange PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
Ascential PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Chesnara PLCFull Year Results
Ebiquity PLCFull Year Results
Gattaca PLCHalf Year Results
Gresham House PLCFull Year Results
IGas Energy PLCFull Year Results
Impellam Group PLCFull Year Results
International Public Partnerships LtdFull Year Results
Ithaca Energy PLCFull Year Results
Microlise Group PLCFull Year Results
Moonpig Group PLCTrading Statement
PetroTal CorpFull Year Results
Renalytix PLCHalf Year Results
Revolution Beauty Group PLCFull Year Results
Robinson PLCFull Year Results
Secure Trust Bank PLCFull Year Results
Supermarket Income REIT PLCHalf Year Results
XLMedia PLCFull Year Results
Friday 31 March 
Amaroq Minerals LtdFull Year Results
Bank of Cyprus Holdings PLCFull Year Results
Computacenter PLCFull Year Results
Cooks Coffee Co LtdFull Year Results
CT Private Equity Trust PLCFull Year Results
Dignity PLCFull Year Results
ECO Animal Health Group PLCTrading Statement
HealthBeacon PLCFull Year Results
Impax Environmental Markets PLCFull Year Results
James Halstead PLCHalf Year Results
Jaywing PLCTrading Statement
JPMorgan American Investment Trust PLCFull Year Results
Numis Corp PLCTrading Statement
Mothercare PLCTrading Statement
Quarto Group IncFull Year Results
UK Oil & Gas PLCFull Year Results
Vanquis Banking Group PLCFull Year Results
Monday 3 April 
Downing Renewables & Infrastructure Trust PLCFull Year Results
Elixirr International PLCFull Year Results
Fidelity Japan Trust PLCFull Year Results
Gaming Realms PLCFull Year Results
HydrogenOne Capital Growth PLCFull Year Results
N4 Pharma PLCFull Year Results
Renew Holdings PLCTrading Statement
Tracsis PLCHalf Year Results
Tuesday 4 April 
accesso Technology Group PLCFull Year Results
Anexo Group PLCTrading Statement
Epwin Group PLCFull Year Results
Merchants Trust PLCFull Year Results
Renewi PLCTrading Statement
Saga PLCFull Year Results
Wednesday 5 April 
EnQuest PLCFull Year Results
Futura Medical PLCFull Year Results
Hilton Food Group PLCFull Year Results
Lookers PLCFull Year Results
Lords Group Trading PLCFull Year Results
RS Group PLCTrading Statement
Topps Tiles PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
29 Mar 2023 09:52

IN BRIEF: Futura responds to US FDA on erectile dysfunction treatment

Futura Medical PLC - Surrey, England-based sexual health-focused pharmaceutical company - Says it has submitted a full response to questions from the US Food & Drug Administration and confirmatory data regarding its MED3000 erectile dysfunction treatment. This is for the FDA to continue its review of the product. Notes that it expects the grant of the De Novo request in the second quarter of 2023. A De Novo classification by the FDA provides an alternate pathway to marketing approval for novel medical devices.

Read more
14 Mar 2023 14:33

Futura Medical confirms Europe launch of MED3000; awaits FDA approval

(Alliance News) - Futura Medical PLC on Tuesday said its MED3000 product is now available online in Europe under the brand name Erexon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account